Asia Pacific Single-Use Bioreactors Market (2026-2031)
The Asia Pacific Single-Use Bioreactors Market was valued at $1357.1 Million in 2026 and projected to reach to $2593.7 Million by 2031, representing a compound annual growth rate of 13.8%. Asia Pacific's single-use bioreactors market is positioned for exceptional growth, driven by expanding biopharmaceutical manufacturing capabilities and substantial investments in cell and gene therapy infrastructure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Asia Pacific Single-Use Bioreactors Market Trends and Insights
- Asia Pacific's accelerating growth trajectory reflects increasing biopharmaceutical manufacturing capacity, rising investment in cell and gene therapy platforms, and regulatory support for advanced bioprocessing technologies across the region.
- Asia Pacific's 13.8% compound annual growth rate significantly outpaces global trends, driven by expanding contract manufacturing organizations (CMOs) and growing demand for flexible, cost-effective bioreactor solutions. Asia Pacific's market expansion is underpinned by rapid industrialization in countries including China, India, and South Korea, where biopharmaceutical production capabilities are scaling rapidly.
- Asia Pacific's adoption of single-use bioreactors is accelerating due to reduced capital expenditure, faster time-to-market, and lower contamination risks compared to traditional stainless-steel systems.
- Between 2026 and 2031, Asia Pacific is expected to capture an increasingly significant share of global bioreactor demand, positioning the region as a critical hub for biologics manufacturing and innovation..
Key Market Statistics
- CAGR (2026-2031) 13.8% CAGR
- Market Size, 2026 ~USD 1357.1 Million
- Forecast, 2031 ~USD 2593.7 Million
- Geography Asia Pacific
Asia Pacific Single-Use Bioreactors Market Overview
Rapid Market Expansion :
Asia Pacific single-use bioreactors market is growing at 13.8% CAGR, outpacing the global rate of 12%, driven by increasing biopharmaceutical manufacturing investments across the region.
Cell & Gene Therapy Surge :
Rising adoption of advanced cell and gene therapy platforms in Asia Pacific is accelerating demand for single-use bioreactor systems, particularly in China, South Korea, and India.
Regulatory Support & Infrastructure :
Strengthened regulatory frameworks and government initiatives supporting bioprocessing technologies are enabling faster market penetration and manufacturing capacity expansion across Asia Pacific nations.
Market Valuation Growth :
The Asia Pacific market is valued at $1,357.1 million in 2026 and is projected to nearly double to $2,593.7 million by 2031, representing significant investment opportunities.
Asia Pacific Single-Use Bioreactors Market Dynamics
- China, South Korea, and India are emerging as key growth hubs, supported by favorable regulatory environments and increasing government backing for advanced bioprocessing technologies.
- The region's growing contract manufacturing organization (CMO) sector and rising demand for personalized medicine solutions are further accelerating market adoption. The forecast period through 2031 will witness intensified competition and technological innovation as regional players establish manufacturing facilities and partnerships with global biopharmaceutical companies.
- Increasing healthcare expenditure, coupled with rising prevalence of chronic diseases, will drive demand for biotherapeutics and consequently boost single-use bioreactor adoption.
- Asia Pacific's cost-competitive manufacturing landscape and skilled workforce will continue to attract foreign direct investment, solidifying the region's position as a critical hub for global biopharmaceutical production..
Market Ecosystem
SINGLE-USE BIOREACTORS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Deployed six 4,000 L ABEC CSR single-use bioreactors at its Pune facility to support large-scale manufacturing of Novavax’s NVX-CoV2373 vaccine. | Established 24,000 L of single-use production capacity | The 4,000 L systems doubled productivity per unit of floor space, supported accelerated facility startup, and reduced manufacturing cost per dose. |
 |
Implemented Cytiva Xcellerex Disposable Reactors (XDR) for mAb and bispecific antibody production. | Demonstrated that XDR bioreactors can be used effectively for antibody production | The system met all benchmarks for viable cell density, viability, integral viable cell count (IVC), and titer | The real-time CO2 monitoring proved effective, allowing maintenance of optimal culture conditions. |
 |
Implemented Sartorius Ambr and BIOSTAT STR platforms, ranging from process-development systems to 500 L and 2,000 L single-use bioreactors, at its San Diego biologics facility. | Enabled consistent scale-up from development to GMP production, improved process-data continuity, and supported seamless technology transfer for Phase I through commercial biologics manufacturing. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Asia Pacific's single-use bioreactors market will grow from $1,357.1M (2026) to $2,593.7M (2031) at a 13.8% CAGR, outpacing global growth rates.
- Asia Pacific's expanding CMO sector and rising biopharmaceutical manufacturing investments are primary drivers of market acceleration across the region.
- Asia Pacific's adoption of single-use systems is accelerating due to cost efficiency, reduced contamination risk, and faster deployment compared to traditional bioreactors.
- Asia Pacific's emerging markets in China, India, and South Korea represent the highest-growth opportunities for single-use bioreactor manufacturers through 2031.
Single-Use Bioreactors Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | CELL & GENE THERAPY (Molecule Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12% from 2026 to 2031 |
| Largest Segment | BIOPRODUCTION (Application) |
| Market Size Base Year (Billions) | ~USD 5.44 (2026) |
| Revenue Forecast (Billions) | ~USD 9.58 (2031) |
| Segments Covered | Product, Scale Range, Type, Molecule Type, Cell Type, Application, Process Mode, End User |
Asia Pacific Single-Use Bioreactors Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product
- Other Products
- Single-Use Assemblies
- Single-Use Bags
- Single-Use Bioreactor Systems
By Scale Range
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- <=10 L Bioreactors
By Type
- 101-500 L Bioreactors
- 11-100 L Bioreactors
- 2D Single-Use Bags
- 3D Single-Use Bags
- 501-1,500 L Bioreactors
- >1,500 L Bioreactors
- Bubble-Column Single-Use Bioreactors
- Fixed-Bed Single-Use Bioreactors
- Other Single-Use Bioreactors
- Stirred-Tank Single-Use Bioreactors
- Wave-Induced Single-Use Bioreactors
- <=10 L Bioreactors
By Molecule Type
- Cell & Gene Therapy
- Monoclonal Antibodies
- Therapeutic Proteins & Peptides
- Vaccines
By Cell Type
- Bacterial Cells
- Mammalian Cells
- Other Cells
- Yeast Cells
By Application
- Bioproduction
- Process Development
- Research & Development
By Process Mode
- Batch Process Mode
- Feb-Batch Process Mode
- Fed-Batch Process Mode
- Perfusion/Continuous Process Mode
By End User
- Academic & Research Institutes
- Cros & Cmos
- Pharmaceutical & Biotechnology Companies
Target Audience
- Biopharmaceutical Manufacturers : Manufacturers expanding production capacity in Asia Pacific need market data to assess regional demand, identify optimal locations, and plan single-use bioreactor investments for cost-effective bioprocessing.
- Contract Manufacturing Organizations (CMOs) : CMOs operating or planning to establish facilities in Asia Pacific require insights into market growth, client demand patterns, and technology adoption trends to guide capacity planning and service offerings.
- Equipment & Technology Suppliers : Bioreactor manufacturers and bioprocessing technology providers need regional market intelligence to identify customer segments, assess competitive dynamics, and develop targeted go-to-market strategies.
- Private Equity & Venture Capital Investors : Investment firms evaluating biotech and biopharmaceutical opportunities in Asia Pacific require market sizing and growth forecasts to assess portfolio companies and identify acquisition targets.
- Healthcare Policy & Regulatory Bodies : Government agencies and regulatory organizations need market data to inform bioprocessing infrastructure development, incentive programs, and policies supporting biopharmaceutical manufacturing growth.
Countries within Asia Pacific - compare and drill down
| Country | 2025 size (native) |
|---|---|
| China | USD 623.3 Million |
| South Korea | USD 243.5 Million |
| Japan | USD 91.5 Million |
| India | USD 106.6 Million |
| Australia | USD 33.4 Million |
| Rest Of Asia Pacific | USD 87.8 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Intelligence : Gain comprehensive insights into Asia Pacific's single-use bioreactors market dynamics, including country-specific growth drivers, competitive landscape, and emerging opportunities across China, South Korea, Japan, and India.
- Investment Decision Support : Access detailed market sizing and forecasts (2026-2031) to identify high-potential markets and optimize capital allocation strategies for biopharmaceutical manufacturing expansion in Asia Pacific.
- Regulatory & Policy Insights : Understand region-specific regulatory frameworks and government support mechanisms driving single-use bioreactor adoption, enabling compliant market entry and partnership strategies.
- Competitive Positioning : Benchmark your organization against regional competitors and identify market gaps in cell and gene therapy bioprocessing capabilities to strengthen your competitive advantage.
- Growth Opportunity Identification : Leverage detailed analysis of emerging trends in contract manufacturing, personalized medicine, and biotech infrastructure development to identify and capitalize on high-growth segments.
Frequently asked questions
What is the projected market size for single-use bioreactors in Asia Pacific by 2031?
Asia Pacific's single-use bioreactors market is projected to reach $2,593.7 million by 2031, growing from $1,357.1 million in 2026.
What is the CAGR for Asia Pacific's single-use bioreactors market?
Asia Pacific's single-use bioreactors market is expected to grow at a compound annual growth rate of 13.8% between 2026 and 2031.
Which countries in Asia Pacific are driving single-use bioreactor market growth?
China, India, and South Korea are leading growth drivers in Asia Pacific, supported by expanding biopharmaceutical manufacturing capacity and CMO investments.
Why is Asia Pacific adopting single-use bioreactors faster than other regions?
Asia Pacific's rapid adoption is driven by lower capital costs, reduced contamination risks, faster deployment timelines, and growing demand from contract manufacturers and emerging biotech companies.
How does Asia Pacific's growth rate compare to the global single-use bioreactors market?
Asia Pacific's 13.8% CAGR significantly exceeds the global market CAGR of 12%, reflecting the region's accelerating biopharmaceutical manufacturing expansion.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global single-use bioreactors market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single-use bioreactors market. The secondary sources used for this study include National Institutes of Health (NIH), National Institute for Bioprocessing Research and Training (NIBRT), Society for Biological Engineering (SBE), Bio-Process Systems Alliance (BPSA), Biotechnology Innovation Organization (BIO), BioProcess International, BioPharm International, BioPlan Associates, Organisation for Economic Co-operation and Development (OECD) R&D Expenditure, National Center for Biotechnology Information (NCBI), World Health Organization (WHO), Food and Drug Administration (FDA); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, and professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-use bioreactors market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain precise statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Single-use bioreactors (SUBs) or disposable bioreactors consist of a disposable bag instead of a typical stainless steel or glass culture vessel. SUBs are based on single-use technology, which uses disposable components to manufacture biopharmaceutical products. The key benefits of single-use bioreactors include reduced risk of cross-contamination, lower capital and operational costs, faster turnaround times, and greater manufacturing flexibility. These advantages make single-use systems particularly attractive for producing biologics, vaccines, and personalized medicines, where flexibility, speed, and sterility are paramount.
The report presents the market size for single-use bioreactor systems, single-use bags, single-use assemblies, and other products that can be incorporated with single-use bioreactors.
Key Stakeholders
- Manufacturers of single-use bioreactors and associated products
- Distributors of single-use bioreactors and related products
- Pharmaceutical and biotechnology companies
- Contract manufacturing companies (CMOs)
- Contract research organizations (CROs)
- Academic and research institutes
- Life sciences companies
- Market research and consulting firms
- Venture capitalists and investors
- Government organizations
- Medical institutes and universities
- Private research firms
Report Objectives
- To define, describe, and forecast the global single-use bioreactors market based on product, type, cell type, process mode, molecule type, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall single-use bioreactors market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the single-use bioreactors market
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the single-use bioreactors market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe single-use bioreactors market, by country
- A further breakdown of the Rest of Asia Pacific single-use bioreactors market, by country
- A further breakdown of the Rest of Latin America single-use bioreactors market, by country
Get the Full Single-Use Bioreactors Market Report
Full forecast, segment splits, and company analysis for all Single-Use Bioreactors Market.
- Canada Single-Use Bioreactors Market
- US Single-Use Bioreactors Market
- Germany Single-Use Bioreactors Market
- UK Single-Use Bioreactors Market
- France Single-Use Bioreactors Market
- Italy Single-Use Bioreactors Market
- Spain Single-Use Bioreactors Market
- China Single-Use Bioreactors Market
- South Korea Single-Use Bioreactors Market
- Japan Single-Use Bioreactors Market
- India Single-Use Bioreactors Market
- Australia Single-Use Bioreactors Market
- Brazil Single-Use Bioreactors Market
- Mexico Single-Use Bioreactors Market
- Rest Of Europe Single-Use Bioreactors Market
- Rest Of Asia Pacific Single-Use Bioreactors Market
- Rest Of Latin America Single-Use Bioreactors Market
- Rest Of GCC Countries Single-Use Bioreactors Market
- Saudi Arabia (Ksa) Single-Use Bioreactors Market
- United Arab Emirates (UAE) Single-Use Bioreactors Market
- GCC Countries Single-Use Bioreactors Market
- Rest Of Middle East Single-Use Bioreactors Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
